Even if there were strong theoretical grounds for believing ABL might be of value in coronavirus infections (and I’m not convinced that is the case), without any experimental evidence that it could be of benefit, it would be a shot in the dark that I cannot see the FDA considering. Personally, I can’t see any prospects there at all.